繁體
简体中文
繁體中文

高宏集團 COWN

等待開盤 03-26 09:30:00 美东时间

38.99

0.000

0.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 成交量 0股
  • 最 低 --
  • 昨 收 38.99
  • 總市值 11.01亿
  • 52周最高 38.95
  • 市盈率 17.65
  • 換手率 0.00%
  • 52周最低 20.97
  • 委 比 0.00%
  • 總股本 2824.23万
  • 歷史最高 43.27
  • 量 比 0
  • 振 幅 0.00%
  • 歷史最低 4.61
  • 每 手 1
  • 風險率 0.00%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Why Are DraftKings Shares Trading Lower On Wednesday?

    DraftKings (DKNG) stock drops as prediction market competition from Kalshi and Polymarket intensifies. Read why analysts are cutting estimates and how regulatory heat from AOC and Martin Shkreli is impacting the sports betting sector.

    今天 03:00

  • Costco creates some buzz in the energy drink market

    Costco Wholesale (COST) has quietly launched a new Kirkland energy drink at some stores. While the company has not issued a formal announcement with details about the launch, social media accounts hav...

    今天 01:39

  • Biogen and Alteogen ink licensing deal for injectables

    Alteogen on Wednesday announced an exclusive license agreement with Biogen (BIIB) to develop subcutaneously delivered biologics leveraging the South Korean pharma's Hybrozyme platform technology. At t...

    今天 00:20

  • Takeda revamps business seeking ¥200B in savings by FY28

    Takeda (TAK) announced plans to generate more than ¥200B ($1.3B) in annualized gross savings by fiscal 2028 on Wednesday, citing a business transformation exercise and a recently undertaken restructur...

    03-25 22:27

  • BUZZ-Apogee Therapeutics resumes climb after $350 mln share sale

    BUZZ-Apogee Therapeutics resumes climb after $350 mln share sale ** Apogee Therapeutics APGE.O shares up 13.3% at $82.68 early Weds after $350 mln follow-on offering priced ** Waltham, Massachusetts-based firm late Tues announced 5 mln shares at $70, a 4.1% discount to last sale ** On Tues, APGE sha

    03-25 22:14

  • Sarepta gains on data for muscular dystrophy therapies

    Sarepta Therapeutics (SRPT) added ~25% in the morning hours on Wednesday after the company posted initial data from Phase 1/2 trials for its experimental drugs targeted at two rare forms of muscular d...

    03-25 21:49

  • Recursion names Vicki Goodman as CMO

    Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in...

    03-25 20:44

  • SSR Mining confirms Çöpler mine sale in $1.5B deal

    SSR Mining (SSRM) up 5.3% pre-market Wednesday after confirming an agreement to sell its 80% ownership stake in the Çöpler mine and related properties in Turkey to Cengiz Holding, one of the country's...

    03-25 19:47

  • Nanobiotix gains after report on J&J buyout bid

    Nanobiotix (NBTX) shares rose ~7% in Paris on Wednesday after the French publication La Lettre reported that U.S. pharma giant Johnson & Johnson (JNJ) is eyeing a buyout deal to acquire the cancer dru...

    03-25 19:03

  • Apogee Therapeutics prices USD 350 million follow-on offering at USD 70 per share

    Apogee Therapeutics prices USD 350 million follow-on offering at USD 70 per share Apogee priced an underwritten public offering of 5,000,000 common shares at USD 70 per share. Gross proceeds are expected to be about USD 350 million. The underwriters have a 30-day option to buy up to 750,000 addition

    03-25 09:55